CILOA’S CUSTOMIZED EXOSOMES FOR INNOVATIVE THERAPEUTICS. Ciloa is the Pioneer exosome Company with the highest R&D experience on recombinant exosomes. Ciloa innovative platform allows to develop Therapeutic Vectors, Therapeutic Antibodies and Adjuvant- & Virus-Free Vaccines. Ciloa customizes exosomes in vivo to contain i) fully native membrane protein complexes (GPCRs, Kinase Rec., Transporters, Ion Channels, Viral Antigens, …) embedded in their membrane and ii) any proteins inside their cytosol